CLSI GP47 (R2019)

Management of Critical- and Significant-Risk Results, 1st Edition, GP47Ed1E, GP47ESEd1E

Clinical and Laboratory Standards Institute, 12/01/2015

Publisher: CLSI

File Format: PDF

$90.00$180.00


Published:01/12/2015

Pages:112

File Size:2 files , 7.2 MB

Note:This product is unavailable in Russia, Belarus

This guideline provides current best practice recommendations for developing and implementing a policy and procedures for the identification, reporting, and management of critical- and significant-risk laboratory results. Emphasis is placed on management responsibilities such as development of the policy, the process, procedures, job descriptions, and monitoring systems that ensure effective reporting and compliance with regulatory requirements.

Executive Summary
This is an executive summary of GP47–Management of Critical- and Significant-Risk Results. It provides a compilation of all key recommendations from GP47 for policies and processes as well as risk management principles and information technology for the management of laboratory results that indicate critical or significant risk to patients.

More CLSI standard pdf

CLSI M32-P

CLSI M32-P

Evaluation of Lots of Mueller Hinton Broth for Antimicrobial Susceptibility Testing; Proposed Guideline, M32PE

$148.00 $296.89

CLSI M37A2

CLSI M37A2

Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters for Veterinary Antimicrobial Agents; Approved Guideline, M37-A2

$129.00 $258.75

CLSI H30-A2

CLSI H30-A2

Procedure for the Determination of Fibrinogen in Plasma; Approved Guideline, H30-A2

$122.00 $245.21

CLSI X03R

CLSI X03R

Implementing a Needlestick and Sharps Injury Prevention Program in the Clinical Laboratory, X03-R

$90.00 $180.00